Dr. Holly Held Volz, MD

Dr. Volz practices at Thushan N Desilva MD in San Antonio, Texas.

Dr. Volz's NPI, 1114337318, was assigned on April 28, 2014. Dr. Volz graduated from Joe R. & Teresa Lozano Long School of Medicine in 2014. Dr. Volz holds Texas license R5819.

Dr. Volz's primary practice is Thushan N Desilva MD, at 12446 West Ave, San Antonio, TX 78216 in Bexar County. The practice phone is (830) 331-4150.

Dr. Volz's primary practice is Thushan N Desilva MD in San Antonio, Texas. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Volz to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Volz practices. Vendor and product names are available with a free account.

Dermatology is Dr. Volz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Volz is board certified in dermatology by the American Board of Dermatology. Dr. Volz is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and minor injury to a limb among the conditions Dr. Volz treats.

CMS data shows 3,144 Medicare services from Dr. Volz across 12 procedure codes in 2024, for 629 Medicare patients. Medicare paid $127,722 for them. Every service was in an office.

CMS counts 629 Medicare patients who saw Dr. Volz in 2024. The largest group is 65 to 74, with 346 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Volz's median patient age at 66, with 63% women.

In 2024, Dr. Volz wrote 616 Medicare Part D claims for 284 patients. 88% of them were for generic drugs. CMS names the drug for 523 of them, across 13 drugs with 11 or more claims each, at $136,410 in total drug cost. In 2023, CMS named 398 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Volz for performance year 2024, reported as part of a group. Dr. Volz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,014 procedures of removal of skin lesions by Dr. Volz, more than 93% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Volz in 2013. Dr. Volz's most frequent co-author is Thomas M. Brown, MD.

CMS Open Payments shows 739 general payments to Dr. Volz from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $3,229.

Dr. Volz graduated from Joe R. & Teresa Lozano Long School of Medicine in 2014.

Dr. Volz is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.